ZTEK Zentek Ltd.

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite Project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating; and surgical masks, HVAC filters, and personal protective equipment. It is also developing synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is based in Thunder Bay, Canada.

$1.84
As of 05/20/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  Canada
Country of incorporation:  
IPO date:  03/21/2022
Outstanding shares:  99,273,058
Average volume:  58,881
Market cap:   $186,633,349
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   -34.96
PB ratio:   27.48
PS ratio:   264.64
Return on equity:   -128.56%
Net income %:   -1,127.48%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy